Abstract

Objective To study the effects of the antiarrhythmic drugs of propafenone, amiodarone and difthiazem on c-type Kvl. 4 channels in Xenopus laevis oocytes with two-electrode voltage-clamp technique. Methods Defolliculated oocytes (stage V - VI) had transcribed cRNAs of ferret Kvl. 4△N channels injected. The oocytes were continuously perfused with control solution or propafenone, amiodarone and dilthiazem under monitoring of software of Clampfit v 9. 0. Results All of the three drugs blocked ferret Kvl. 4△N channel in voltage-, frequency- and concentration-dependent manners. The values of IC50 (50% inhibiting concentration ) of propafenone, amiodarone and dilthiazem were ( 103.4±2. 2 ) μmol/L, (501.22± 5.9) μmol/L and (353.62 ± 9.9) μmot/L, respectively. The currents under the actions of propafenone , amiodarone and dilthiazem were decreased to 41%, 32% and 21% of control group, respectively. Propafenone (100μmol/L), Amiodarone (500μmol/L), dilthiazem (350μmol/L) inhibited currents to (54. 6 ±1.9 ) %, ( 46. 3 ± 3.5 ) % , ( 52. 8 ± 2. 8 ) % of control group in voltage-dependent blockage. Conclusions The results suggested that all the three drugs blocked the kvl. 4△N channel in the open state. The three drugs block the kvl. 4△N channel maybe had the similiar effects in some respects, but each had its unique characteristics. Key words: Kvl. 4 channel; C-type inactivation; Propafenone ; Amiodarone ; Dilthiazem; Electrophysiology

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.